Additional equipment used in anaesthesia and intensive care

Published on 07/02/2015 by admin

Filed under Anesthesiology

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 3420 times

Additional equipment used in anaesthesia and intensive care

Continuous positive airway pressure (CPAP)

CPAP is a spontaneous breathing mode used in the intensive care unit, during anaesthesia and for patients requiring respiratory support at home. It increases the functional residual capacity (FRC) and improves oxygenation. CPAP prevents alveolar collapse and possibly recruits already collapsed alveoli.

Mechanism of action

1. Positive pressure within the lungs (and breathing system) is maintained throughout the whole of the breathing cycle.

2. The patient’s peak inspiratory flow rate can be met.

3. The level of CPAP varies depending on the patient’s requirements. It is usually 5–15 cm H2O.

4. CPAP is useful in weaning patients off ventilators especially when positive end expiratory pressure (PEEP) is used. It is also useful in improving oxygentaion in type 1 respiratory failure, where CO2 elemination is not a problem.

5. Two levels of airway pressure support can be provided using inspiratory positive airway pressure (IPAP) and expiratory positive airway pressure (EPAP). IPAP is the pressure set to support the patient during inspiration. EPAP is the pressure set for the period of expiration This is commonly used in reference to bilevel positive airway pressure (BiPAP©). Using this mode, the airway pressure during inspiration is independent from expiratory airway pressure. This mode is useful in managing patients with type 2 respiratory failure as the work of breathing is reduced with improvements in tidal volume and CO2 removal.

Problems in practice and safety features

Haemofiltration

Haemofiltration is a process of acute renal support used for critically ill patients. It is the ultrafiltration of blood.

Ultrafiltration is the passage of fluid under pressure across a semipermeable membrane where low molecular weight solutes (up to 20 000 Da) are carried along with the fluid by solvent drag (convection) rather than diffusion. This allows the larger molecules such as plasma proteins, albumin (62 000 Da) and cellular elements to be preserved.

The widespread use of haemofiltration has revolutionized the management of critically ill patients with acute renal failure within the intensive therapy environment (Fig. 13.2). Haemofiltration is popular because of its relative ease of use and higher tolerability in the cardiovascularly unstable patient.

In the critical care setting, haemofiltration can be delivered by:

Components

1. Intravascular access lines. These can either be arteriovenous lines (such as femoral artery and vein or brachial artery and femoral vein) or venovenous lines (such as the femoral vein or the subclavian vein using a single double-lumen catheter). The extracorporeal circuit is connected to the intravascular lines. The lines should be as short as possible to minimize resistance.

2. Filter or membrane (Fig. 13.3). Synthetic membranes are ideal for this process. They are made of polyacrylonitrile (PAN), polysulphone or polymethyl methacrylate. They have a large pore size to allow efficient diffusion (in contrast to the smaller size of dialysis filters).

3. Two roller pumps, one on each side of the circuit. Each pump peristaltically propels about 10 mL of blood per revolution and is positioned slightly below the level of the patient’s heart.

4. The collection vessel for the ultrafiltrate is positioned below the level of the pump.

Mechanism of action

1. At its most basic form, the haemofiltration system consists of a circuit linking an artery to a vein with a filter positioned between the two.

2. The patient’s blood pressure provides the hydrostatic pressure necessary for ultrafiltration of the plasma. This technique is suitable for fluid-overloaded patients who have a stable, normal blood pressure.

3. Blood pressure of less than a mean of 60 or 70 mmHg reduces the flow and the volume of filtrate and leads to clotting despite heparin.

4. In the venovenous system, a pump is added making the cannulation of a large artery unnecessary (Fig. 13.4). The speed of the blood pump controls the maintenance of the transmembrane pressure. The risk of clotting is also reduced. This is the most common method used. Blood flows of 30–750 mL/min can be achieved, although flow rates of 150–300 mL/min are generally used. This gives an ultrafiltration rate of 25–40 mL/min.

5. The fluid balance is maintained by the simultaneous reinfusion of a sterile crystalloid fluid. The fluid contains most of the plasma electrolytes present in their normal values (sodium, potassium, calcium, magnesium, chloride, lactate and glucose) with an osmolality of 285–335 mosmol/kg. Large amounts of fluid are needed such as 2–3 L/h.

6. Pressure transducers monitor the blood pressure in access and return lines. Air bubble detection facilities are also incorporated. Low inflow pressures can happen during line occlusion. High and low post-pump pressures can happen in line occlusion or disconnection respectively.

7. Some designs have the facility to weigh the filtrate and automatically supply the appropriate amount of reinfusion fluid.

8. Heparin is added as the anticoagulant with a typical loading dose of 3000 IU followed by an infusion of 10 IU per kg body weight. Heparin activity is monitored by activated partial thromboplastin time or activated clotting time. Prostacyclin or low molecular weight heparin can be used as alternatives to heparin.

9. The filters are supplied either in a cylinder or flat box casing. The packing of the filter material ensures a high surface area to volume ratio. The filter is usually manufactured as a parallel collection of hollow fibres packed within a plastic canister. Blood is passed, or pumped, from one end to the other through these tubules. One or more ports provided in the outer casing are used to collect the filtrate and/or pass dialysate fluid across the effluent side of the membrane tubules.

Arterial blood gas analyser (Fig. 13.5)

In order to measure arterial blood gases, a sample of heparinized, anaerobic and fresh arterial blood is needed.

The measured parameters are:

From these measurements, other parameters can be calculated, e.g. actual bicarbonate, standard bicarbonate, base excess and oxygen saturation.

Polarographic (Clark) oxygen electrode

This measures the oxygen partial pressure in a blood (or gas) sample (Fig. 13.6).

Mechanism of action

pH electrode

This measures the activity of the hydrogen ions in a sample. Described mathematically, it is:

image

It is a versatile electrode which can measure samples of blood, urine or CSF (Fig. 13.7).

Carbon dioxide electrode (Severinghaus electrode)

A modified pH electrode is used to measure carbon dioxide partial pressure, as a result of change in the pH of an electrolyte solution (Fig. 13.8).

Intra-aortic balloon pump (IABP)

This is a catheter incorporating a balloon which is inserted into the aorta to support patients with severe cardiac failure. Its core principle is synchronized counterpulsation. It is usually inserted using a percutaneous femoral approach, over a guidewire, under fluoroscopic or transoesophageal echo guidance. The correct position of the pump is in the descending aorta, just distal to the left subclavian artery (Fig 13.9).

Components

1. A 7- up to 8-FG catheter with a balloon.

2. The catheter has two lumens, an outer lumen for helium gas exchange to and from the balloon and a fluid-filled central lumen for continuous aortic pressure monitoring via a transducer. The most modern versions use fibre-optics instead to monitor aortic pressure, which is faster and more sensitive, generating faster response times.

3. The usual volume of the balloon is 40 mL. A 34-mL balloon is available for small individuals. The size of the balloon should be 80–90% of the diameter of the aorta. The pump is attached to a console (Fig. 13.10) which controls the flow of helium in and out of the balloon and monitors the patient’s blood pressure and ECG. The console allows the adjustment of the various parameters in order to optimize counterpulsation.

Mechanism of action

1. The balloon is inflated in early diastole, immediately after the closure of the aortic valve. This leads to an increase in peak diastolic blood pressure (diastolic augmentation) and an increase in coronary artery perfusion pressure. This increases myocardial oxygen supply. Inflation should be at the dicrotic notch on the arterial pressure waveform (Fig. 13.11).

2. The balloon is deflated at the end of diastole just before the aortic valve opens and remains deflated during systole. This leads to a decrease in aortic end-diastolic pressure causing a decrease in left ventricular afterload and decreased myocardial oxygen demand. This will lead to an increase in left ventricular performance, stroke work and ejection fraction. Deflation should be at the lowest point of the arterial diastolic pressure.

3. During myocardial ischaemia, the main benefits of the IABP are the reduction of myocardial oxygen demand (by lowering of the left ventricular pressure) and the increase in myocardial oxygen supply (by increasing the coronary artery perfusion).

4. The effectiveness of the balloon depends on the ratio of the balloon to aorta size, heart rate and rhythm, compliance of the aorta and peripheral vessels and the precise timing of the counterpulsation. Correctly timed IABP should be able to increase the augmented diastolic pressure to higher then the systolic pressure. IABP is expected to increase diastolic pressure by 30%, decrease the systolic pressure by 20% and improve cardiac output by 20%.

Intravenous giving sets

These are designed to administer intravenous fluids, blood and blood products (Fig. 13.12).

Components

1. Adult giving set:

2. Paediatric set (Fig. 13.12D):

a) In order to attain accuracy, a burette (30–200 mL) in 1 mL divisions is used to measure the volume of fluid to be infused. The burette has a filter, air inlet and an injection site on its top. At the bottom, there is a flap/ball valve to prevent air entry when the burette is empty.

b) There are two flow controllers: one is between the fluid bag and the burette and is used to fill the burette; the second is between the burette and the patient and controls the drip rate. An injection site should be close to the patient to reduce the dead space.

c) Drop size is 60 drops per 1 mL of clear fluid. A burette with a drop size similar to the adult’s version (15 drops per mL) is used for blood transfusion.

d) 0.2-micron filters can be added in line to filter out air and foreign bodies, e.g. glass or plastic particles. Infusion-related thrombophlebitis can be reduced by the use of these filters.

Intravenous cannulae

Intravenous cannulae are made of plastic. They are made by different manufacturers with different characteristics (Fig. 13.13).

Intravenous cannulae can be either with or without a port. Some designs offer protection against the risk of needle stick injuries (Fig. 13.14), covering the sharp needle tip with a blunt end.

More recent designs are the ‘closed and integrated’ cannulae (Fig. 13.15). A ‘closed’ system may offer better protection against bacterial exposure than conventional ‘open’ ports. As the blood does not naturally escape from the catheter hub, these devices further minimize the risk of exposing the clinician to blood during the insertion procedure.

Using distilled water at a temperature of 22°C and under a pressure of 10 kPa, the flow through a 110-cm tubing with an internal diameter of 4 mm is as follows:

Blood warmers

These are used to warm blood (and other fluids) before administering them to the patient. The aim is to deliver blood/fluids to the patient at 37°C. At this temperature, there is no significant haemolysis or increase in osmotic fragility of the red blood cells. There are various designs with the coaxial fluid/blood warmer devices are most popular (Fig. 13.16). A coaxial tubing is used to heat and deliver the fluids to the patient. The outside tubing carries heated sterile water. The inside tubing carries the intravenous fluid. The sterile water is heated to 40°C and stored by the heating case. The water is circulated through the outside tubing. The intravenous fluid does not come in contact with the circulating water. The coaxial tubing extends to the intravenous cannula reducing the loss of heat as fluid is exposed to room temperature.

For patients requiring large and rapid intravenous therapy, special devices are used to deliver warm fluids (Fig. 13.17). Fluids are pressurized to 300 mmHg and warmed with a countercurrent recirculation fluid at a temperature of 42°C.

Defibrillator

This is a device that delivers electrical energy to the heart causing simultaneous depolarization of an adequate number of myocardial cells to allow a stable rhythm to be established. Defibrillators can be divided into the automated external defibrillators (AEDs) (Fig. 13.19) and manual defibrillators (Fig. 13.20). AEDs offer interaction with the rescuer through voice and visual prompts.

Mechanism of action

1. DC energy rather than AC energy is used. DC energy is more effective causing less myocardial damage and being less arrhythmogenic than AC energy. The lower the energy used, the less the damage to the heart.

2. Transformers are used to step up mains voltage from 240 V AC to 5000–9000 V AC. A rectifier converts it to 5000 V DC. A variable voltage step-up transformer is used so that different amounts of charge may be selected. Most defibrillators have internal rechargeable batteries that supply DC in the absence of mains supply. This is then converted to AC by means of an inverter, and then amplified to 5000 V DC by a step-up transformer and rectifier (Fig. 13.21).

3. The DC shock is of brief duration and produced by discharge from a capacitor. The capacitor stores energy in the form of an electrical charge, and then releases it over a short period of time. The current delivered is maintained for several milliseconds in order to achieve successful defibrillation. As the current and charge delivered by a discharging capacitor decay rapidly and exponentially, inductors are used to prolong the duration of current flow.

4. The external paddles/pads are positioned on the sternum and on the left midaxillary line (fifth–sixth rib). An alternative placement is one paddle positioned anteriorly over the left precordium and the other positioned posteriorly behind the heart. Firm pressure on the paddles is required in order to reduce the transthoracic impedance and achieve a higher peak current flow. Using conductive gel pads helps in reducing the transthoracic impedance. Disposable adhesive defibrillator electrode pads are currently used instead of paddles, offering hands-free defibrillation.

5. Most of the current is dissipated through the resistance of the skin and the rest of the tissues and only a small part of the total current (about 35 A) flows through the heart. The impedance to the flow of current is about 50–150 Ohms; however, repeated administration of shocks in quick succession reduces impedance.

6. Waveform:

a) Monophasic defibrillators deliver current that is unipolar (i.e. one direction of current flow) (Fig. 13.22A). They are not used in modern practice as they were likely to have waveform modification depending on transthoracic impedance (e.g. larger patients with high transthoracic impedance received considerably less transmyocardial current than smaller patients).

b) Biphasic defibrillators deliver a two-phased current flow in which electrical current flows in one direction for a specified duration, then reverses and flows in the opposite direction for the remaining milliseconds of the electrical discharge. Biphasic defibrillators can either be biphasic truncated exponential (BTE) (Fig. 13.22B) or rectilinear biphasic (RLB) (Fig. 13.22C). Biphasic defibrillators compensate for the wide variations in transthoracic impedance by electronically adjusting the waveform magnitude and duration to ensure optimal current delivery to the myocardium, irrespective of the patient’s size.

c) Monophasic vs biphasic performance: as can be seen in Figure 13.23 the highest part of the current waveform is known as the ‘peak current’ when the most current is flowing. Note the difference in height (amps) between the monophasic peak current and the biphasic peak current. Too much peak current during the shock can injure the heart. It’s the peak current, not energy, that can injure the heart. The goal of defibrillation is to deliver enough current to the heart to stop the lethal rhythm but with a low peak current to decrease risk of injury to the heart muscle.

7. For internal defibrillation, the shock delivered to the heart depends on the size of the heart and the paddles.

8. Some designs have an ECG oscilloscope and paper recording facilities. DC defibrillation can be synchronized with the top of the R-wave in the treatment of certain arrhythmias such as atrial fibrillation.

9. The implantable automatic internal defibrillator (Fig. 13.24) is a self-contained diagnostic and therapeutic device placed next to the heart. It consists of a battery and electrical circuitry (pulse generator) connected to one or more insulated wires. The pulse generator and batteries are sealed together and implanted under the skin, usually near the shoulder. The wires are threaded through blood vessels from the implantable cardiac defibrillator (ICD) to the heart muscle. It continuously monitors the rhythm, and when malignant tachyarrhythmias are detected, a defibrillation shock is automatically delivered. ICDs are subject to malfunction due to internal short circuit when attempting to deliver an electrical shock to the heart or due to a memory error. Newer devices also provide overdrive pacing to electrically convert a sustained ventricular tachycardia, and ‘back-up’ pacing if bradycardia occurs. They also offer a host of other sophisticated functions (such as storage of detected arrhythmic events and the ability to do ‘non-invasive’ electrophysiologic testing).

Chest drain

Used for the drainage of air, blood and fluids from the pleural space.

Mechanism of action

1. An air-tight system is required to maintain a subatmospheric intrapleural pressure. The underwater seal acts as a one-way valve through which air is expelled from the pleural space and prevented from re-entering during the next inspiration. This allows re-expansion of the lung after a pneumothorax and restores haemodynamic stability by minimizing mediastinal shift.

2. Under asepsis, skin and subcutaneous tissues are infiltrated with local anaesthetic at the level of the fourth–fifth intercostal space in the midaxillary line. The chest wall is incised and blunt dissection using artery forceps through to the pleural cavity is performed. Using the tip of the finger, adherent lung is swept away from the insertion site.

3. The drain is inserted into the pleural cavity and slid into position (usually towards the apex). The drain is then connected to an underwater seal device.

4. Some designs have a flexible trocar to reduce the risk of trauma.

5. The drainage tube is submerged to a depth of 1–2 cm in the collection chamber (Fig. 13.26). This ensures minimum resistance to drainage of air and maintains the underwater seal even in the face of a large inspiratory effort.

6. The collection chamber should be about 100 cm below the chest as subatmospheric pressures up to −80 cm H2O may be produced during obstructed inspiration.

7. A Heimlich flutter one-way valve can be used instead of an underwater seal, allowing better patient mobility.

8. Drainage can be allowed to occur under gravity or suction of about −15–20 mmHg may be applied.

Problems in practice and safety features

The ultrasound machine (Fig. 13.27)

Ultrasound is a longitudinal high-frequency wave. It travels through a medium by causing local displacement of particles. This particle movement causes changes in pressures with no overall movement of the medium. An ultrasound machine consists of a probe connected to a control unit that displays the ultrasound image.

Mechanism of action

1. The probe transmits and receives the ultrasound beam once placed in contact with the skin via ‘acoustic coupling’ jelly.

2. Ultrasound is created by converting electrical energy into mechanical vibration utilizing the piezoelectric (PE) effect. The PE materials vibrate when a varying voltage is applied. The frequency of the voltage applied determines the frequency of the sound waves produced. The thickness of the PE element determines the frequency at which the element will vibrate most efficiently, i.e. its resonant frequency (RF). RF occurs when the thickness of element is half the wavelength of the sound wave generated.

3. An image is generated when the pulse wave emitted from the transducer is transmitted into the body, reflected off the tissue interface and returned to the transducer. Returning US waves cause PE crystals (elements) within the transducer to vibrate. This causes the generation of a voltage. Therefore, the same crystals can be used to send and receive sound waves.

4. Two-dimensional images of structures are displayed. Procedures requiring precise needle placement such as venous cannulation or nerve blocks can be performed under direct ultrasound control. This helps to minimize the possible risks of the procedure.

5. The image can be displayed in a number of modes:

6. Structures can then be identified via their ultrasound characteristics and anatomical relationships.

7. Increasing the depth allows visualization of deeper structures. The depth of the image should be optimized so that the target is centred in the display image.

8. Transducer probes come in many shapes and sizes (Fig. 13.28). The shape of the probe determines its field of view, and the frequency of emitted sound waves determines how deep the sound waves penetrate and the resolution of the image.

Further reading

Alaour B., English W. Intra-aortic balloon pump counterpulsation. World Anaesthesia Society. Online. Available at http://www.anaesthesiauk.com/Documents/220%20Intra-aortic%20Balloon%20Pump%20Counterpulsation.pdf, 2011.

MHRA. Infusion systems DB 2003(02) v2.0. Online. Available at http://www.mhra.gov.uk/Publications/Safetyguidance/DeviceBulletins/CON007321, 2010.

MHRA. Medical device alert: all chest drains when used with high-flow, low-vacuum suction systems (wall mounted) (MDA/2010/040). Online. Available at http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON081890, 2010.

MHRA. Medical device alert: intravenous (IV) extension sets with multiple ports: all brands (MDA/2010/073). Online. Available at http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON093966, 2010.

MHRA. Medical device alert: IV extension sets with multiple ports and vented caps. Various manufacturers (MDA/2010/068). Online. Available at http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON093757, 2010.

MHRA. Medical device alert: SleepStyle CPAP devices manufactured by Fisher & Paykel Healthcare (MDA/2010/076). Online. Available at http://www.mhra.gov.uk/Publications/Safetywarnings/MedicalDeviceAlerts/CON094175, 2010.

NHS. Chest drains: risks associated with the insertion of chest drains. Online. Available at http://www.nrls.npsa.nhs.uk/resources/?entryid45=59887&p=10, 2009.

NHS. Non-invasive ventilation. Online. Available at http://www.nrls.npsa.nhs.uk/resources/?entryid45=83759&p=2, 2010.

MCQs

In the following lists, which of the statements (a) to (e) are true?

1. Concerning defibrillators:

2. Concerning arterial blood gases analysis:

3. Concerning the CO2 electrode:

4. CPAP:

5. Haemofiltration:

6. Intra-aortic balloons:

7. Chest drains:

Answers

1. Concerning defibrillators:

a) False. DC current is used as the energy generated is more effective and causes less myocardial damage. Also DC energy is less arrhythmogenic than AC energy.

b) False. Joules, not watts, are used to measure the electric energy released.

c) False. The defibrillator consists of a capacitor that stores then discharges the electric energy in a controlled manner. Step-up transformers are used to change mains voltage to a much higher AC voltage. A rectifier converts that to a DC voltage. Inductors are used to prolong the duration of current flow as the current and charge delivered by a discharging capacitor decay rapidly and exponentially.

d) True. Because of the high energy release, skin burns can be caused by defibrillators especially if gel pads are not used.

e) False. The amount of electrical energy used in internal defibrillation is a very small fraction of that used in external defibrillation. In internal defibrillation, the energy is delivered directly to the heart. In external defibrillation, a large proportion of the energy is lost in the tissues before reaching the heart.

2. Concerning arterial blood gases analysis:

a) True. Heparin is added to the blood sample to prevent clotting during the analysis. Heparin should only fill the dead space of the syringe and form a thin layer on its interior. Heparin is acidic and in excess will increase the hydrogen ion concentration (lowering the pH) of the sample.

b) False. As air consists of about 21% oxygen in nitrogen, the addition of an air bubble(s) to the blood sample will increase the oxygen partial pressure in the sample.

c) False. At room temperature, the metabolism of the cells in the blood sample will continue. This leads to a low oxygen partial pressure and a high H+ concentration and CO2 partial pressure. If there is a delay in the analysis, the sample should be kept on ice.

d) False. The normal H+ concentration is 40 nanomol/L, which is equivalent to a pH of 7.4.

e) True. CO2 partial pressure in a sample can be measured by measuring the changes in pH of an electrolyte solution using a modified pH electrode. The CO2 diffuses across a membrane separating the sample and the electrolyte solution. The CO2 reacts with the water present producing H+ ions resulting in changes in pH.

3. Concerning the carbon dioxide electrode:

4. CPAP:

5. Haemofiltration:

a) True. Solutes of up to 20 000 Da molecular weight are carried along the semipermeable membrane with the fluid by solvent drag (convection).

b) False. One of the reasons for the popularity of haemofiltration in the intensive care unit setup is that it has a higher tolerability in cardiovascularly unstable patients.

c) True. Although blood flows of 30–750 mL/min can be achieved during haemofiltration, blood flows of 150–300 mL/min are commonly used. This gives a filtration rate of 25–40 mL/min.

d) False. Heparin is the anticoagulant of choice during haemofiltration. If there is a contraindication for its use, prostacyclin can be used instead.

e) False. The filters have a large surface area with large pore size and are packed in such a way as to ensure a high surface area to volume ratio. The optimal surface area is 0.5–1.5 m2.

6. Intra-aortic balloons:

a) True. The usual volume of the balloon is 40 mL. A smaller version, 34 mL, can be used in small patients. The size of the balloon should be 80–90% of the diameter of the aorta.

b) False. The balloon should be inflated in early diastole immediately after the closure of the aortic valve at the dicrotic notch of the arterial waveform. This leads to an increase in coronary artery perfusion pressure.

c) True. This leads to a decrease in aortic end-diastolic pressure so reducing the left ventricular afterload and myocardial oxygen demand.

d) False. Aortic dissection is one of the absolute contraindications to intra-aortic balloon pump.

e) True. Helium is used to inflate the balloon. Because of its physical properties (low density) it allows rapid and complete balloon inflation and deflation.

7. Chest drains:

8. c)

9. c)